Parkside Financial Bank & Trust »

Bioxcel Therapeutics shares owned by Parkside Financial Bank & Trust

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Parkside Financial Bank & Trust from 13F filings

Historical chart of Parkside Financial Bank & Trust investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Parkside Financial Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Parkside Financial Bank & Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $287 112 2.56
2025-06-30 $203 112 1.81
2025-03-31 $227 112 2.04

More positions owned by Parkside Financial Bank & Trust

Blackrock (BLK)
Apple (AAPL)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Val Etf (IWD)
Spdr S&p 500 Etf Tr Put Put Option (Principal) (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Msci Eafe Etf (EFA)

View all positions for Parkside Financial Bank & Trust

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
FMR
Vanguard Group
Geode Capital Management
XTX Topco
BlackRock
State Street Corporation
UBS Group
Oaktree Fund Advisors
Northern Trust
Jones Financial Companies, L.L
HighTower Advisors
Foundations Investment Advisors
SLT Holdings

View all funds holding Bioxcel Therapeutics